Logo-ipp

Immunopathol Persa. 2024;10(2): e39477. doi: 10.34172/ipp.2023.39477

Original

Investigating the expression of cytokeratin 5/6 in benign and malignant breast lesions

Seyed Abbas Rezaei Naserabad 1 ORCID, Shahram Bagheri 1 * ORCID, Parvin Kheradmand 1 ORCID, Seyed Mahmoud Latifi 2 ORCID

Cited by CrossRef: 3

1- Rahimi H, Farzadifar E, Mottaghi-Dastjerdi N, Ghorbani A, Amerizadeh F, Pasdar A. Integrative Systems Biology Analysis of MicroRNA Regulation in Wnt Signaling Pathway During Breast Cancer Progression. Int J Cancer Manag. 2025;18(1) [Crossref]
2- Bahadoran E, Moghbelinejad S, Mohammadi G, Shahbazmohammadi H, Abdolvahabi Z, Jalilvand M, Zare I, Alaei M, Keshavarz Shahbaz S. Cytokeratin expression in breast cancer: from mechanisms, progression, diagnosis, and prognosis to therapeutic implications. Molecular & Cellular Oncology. 2025;12(1) [Crossref]
3- Hachani K, Yazdi M, Carcopino C, Khademi Moghadam F, Smith M, Trill A, Trefny M, Hasanzadeh Kafshgari M, Hoch C, Gaballa A, Alkotub B, Altomonte J, Pockley A, Wagner E, Wollenberg B, Kobold S, Multhoff G, Bashiri Dezfouli A. Development of CAR NK Cell Lines Selectively Targeting Cancer Cells Expressing Membrane Hsp70. MedComm. 2026;7(5) [Crossref]